566 related articles for article (PubMed ID: 31547815)
1. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy.
Liu Y; Liu X; Jia J; Zheng J; Yan T
J Transl Med; 2019 Sep; 17(1):320. PubMed ID: 31547815
[TBL] [Abstract][Full Text] [Related]
2. ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy.
Liu Y; Zheng J; Zhao N; Jia J; Yan T
Dis Markers; 2019; 2019():2407067. PubMed ID: 31275443
[TBL] [Abstract][Full Text] [Related]
3. ST6Gal1 is up-regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: An integrated analysis of the transcriptome.
Liu Y; Wang F; Zhang Y; Jia J; Yan T
J Cell Mol Med; 2020 Sep; 24(18):10493-10500. PubMed ID: 32677771
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.
Camilla R; Suzuki H; Daprà V; Loiacono E; Peruzzi L; Amore A; Ghiggeri GM; Mazzucco G; Scolari F; Gharavi AG; Appel GB; Troyanov S; Novak J; Julian BA; Coppo R
Clin J Am Soc Nephrol; 2011 Aug; 6(8):1903-11. PubMed ID: 21784819
[TBL] [Abstract][Full Text] [Related]
5. Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.
Hastings MC; Moldoveanu Z; Julian BA; Novak J; Sanders JT; McGlothan KR; Gharavi AG; Wyatt RJ
Clin J Am Soc Nephrol; 2010 Nov; 5(11):2069-74. PubMed ID: 20634323
[TBL] [Abstract][Full Text] [Related]
6. TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy.
Zheng N; Xie K; Ye H; Dong Y; Wang B; Luo N; Fan J; Tan J; Chen W; Yu X
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32699192
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T
PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165
[TBL] [Abstract][Full Text] [Related]
8. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
Bagchi S; Lingaiah R; Mani K; Barwad A; Singh G; Balooni V; Bhowmik D; Agarwal SK
PLoS One; 2019; 14(3):e0214256. PubMed ID: 30917188
[TBL] [Abstract][Full Text] [Related]
9. Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.
Xie YX; He LY; Chen X; Peng XF; Ye MY; Zhao YJ; Yan WZ; Liu C; Shao J; Peng YM
Int Urol Nephrol; 2016 Nov; 48(11):1855-1861. PubMed ID: 27465795
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy.
Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Ohta K; Yachie A
J Immunol Res; 2020; 2020():4284379. PubMed ID: 32537466
[TBL] [Abstract][Full Text] [Related]
11. Changes E3 ubiquitin protein ligase 1 gene mRNA expression correlated with IgA1 glycosylation in patients with IgA nephropathy.
Liu Y; Zheng J; Jia J; Li H; Hu S; Lin Y; Yan T
Ren Fail; 2019 Nov; 41(1):370-376. PubMed ID: 31057023
[TBL] [Abstract][Full Text] [Related]
12. C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy.
Xing Y; Li L; Zhang Y; Wang F; He D; Liu Y; Jia J; Yan T; Lin S
BMC Nephrol; 2020 Jan; 21(1):18. PubMed ID: 31941451
[TBL] [Abstract][Full Text] [Related]
13. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
Zhang K; Li Q; Zhang Y; Shang W; Wei L; Li H; Gao S; Yan T; Jia J; Liu Y; Lin S
Kidney Blood Press Res; 2019; 44(5):1196-1206. PubMed ID: 31574506
[TBL] [Abstract][Full Text] [Related]
15. Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
Zachova K; Jemelkova J; Kosztyu P; Ohyama Y; Takahashi K; Zadrazil J; Orsag J; Matousovic K; Galuszkova D; Petejova N; Mestecky J; Raska M
J Am Soc Nephrol; 2022 May; 33(5):908-917. PubMed ID: 35115327
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
Sugiyama M; Wada Y; Kanazawa N; Tachibana S; Suzuki T; Matsumoto K; Iyoda M; Honda H; Shibata T
PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
[TBL] [Abstract][Full Text] [Related]
17. Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis.
Zhang X; Xie X; Shi S; Liu L; Lv J; Zhang H
Nephrol Dial Transplant; 2020 Dec; 35(12):2117-2123. PubMed ID: 31377786
[TBL] [Abstract][Full Text] [Related]
18. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.
Yanagawa H; Suzuki H; Suzuki Y; Kiryluk K; Gharavi AG; Matsuoka K; Makita Y; Julian BA; Novak J; Tomino Y
PLoS One; 2014; 9(5):e98081. PubMed ID: 24858067
[TBL] [Abstract][Full Text] [Related]
19. Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.
Kim MJ; Schaub S; Molyneux K; Koller MT; Stampf S; Barratt J
PLoS One; 2016; 11(12):e0166830. PubMed ID: 27930655
[TBL] [Abstract][Full Text] [Related]
20.
Liu XZ; Zhang YM; Jia NY; Zhang H
Ren Fail; 2020 Nov; 42(1):539-546. PubMed ID: 32524871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
